PDF 1.516kB - TOBIAS-lib - Universität Tübingen

Literaturverzeichnis
Mariya Gosheva
polymorphism is a major determinant of clopidogrel responsiveness in healthy
subjects. Blood. 2006, 108: 2244-2247.
67. Mega, JL, Close, SL, Wiviott, SD, Shen, L, Hockett, RD, Brandt, JT,
Walker, JR, Antman, EM, Macias, W, Braunwald, E and Sabatine, MS.
Cytochrome P450 polymorphisms and response to clopidogrel. N Engl J Med.
2009, 360: 354-362.
68. Bates, ER, Lau, WC and Bleske, BE. Loading, pretreatment, and
interindividual variability issues with clopidogrel dosing. Circulation. 2005, 111:
2557-2559.
69. Tentzeris, I, Siller-Matula, J, Farhan, S, Jarai, R, Wojta, J and Huber, K.
Platelet function variability and non-genetic causes. Thromb Haemost. 2011,
105: 60-66.
70. Fontana, P, Dupont, A, Gandrille, S, Bachelot-Loza, C, Reny, JL, Aiach,
M and Gaussem, P. Adenosine diphosphate-induced platelet aggregation is
associated with P2Y12 gene sequence variations in healthy subjects.
Circulation. 2003, 108: 989-995.
71. Geisler, T, Grass, D, Bigalke, B, Stellos, K, Drosch, T, Dietz, K, Herdeg,
C and Gawaz, M. The residual platelet aggregation after deployment of
intracoronary stent (PREDICT) score. J Thromb Haemost. 2008, 6: 54-61.
72. Rana, JS, Nieuwdorp, M, Jukema, JW and Kastelein, JJP.
Cardiovascular metabolic syndrome - an interplay of obesity, inflammation,
diabetes and coronary heart disease. Diabetes Obes Metab. 2007, 9: 218-232.
73. Lenz, M, Richter, T and Mühlhauser, I. Morbidität und Mortalität bei
Übergewicht und Adipositas im Erwachsenalter. Deutsches Ärzteblatt. 2009, 40:
641-648.
74. Ades, PA, Savage, PD, Toth, MJ, Schneider, DJ, Audelin, MC, Bunn, JY
and Ludlow, M. The influence of obesity and consequent insulin resistance on
coronary risk factors in medically treated patients with coronary disease. I J
Obesity. 2008, 32: 967-974.
75. Levi, J, Gray, SL, Speck, M, Huynh, FK, Babich, SL, Gibson, WT and
Kieffer, TJ. Acute disruption of Leptin signaling in vivo leads to increased
insulin levels and insulin resistance. Endocrinology. 2011, 152: 3385-3395.
76. van de Woestijne, AP, Monajemi, H, Kalkhoven, E and Visseren, FL.
Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and
management. Obes Rev. 2011, 12: 829-840.
77. Dandona, P, Aljada, A and Bandyopadhyay, A. Inflammation: the link
between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25: 4-
7.
- 64 -